@normunity

Biotechnology company creating a new class of precision immuno-oncology medicines called immune normalizers that free the body’s normal immunity against cancer.

 Boston, MA and West Haven, CT
normunity.com/
Joined October 2022
  • Tweets12
  • Following4
  • Followers34
8Media
With new #startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’ biopharmadive.com/news/normu… $NXTC $AZN $BMY $MRK

With new startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’

Chen, who discovered the cancer-protecting protein PD-L1, will work closely with startup Normunity to find targets that can help the immune system reach ‘cold’ tumors.

biopharmadive.com
1
3
1
4
Normunity, which combines the words normal and immunity, is launching out of stealth with a $65 million Series A. The 15-month-old West Haven and Boston-based biotech wants to address T cell exclusion, or when T cells can’t get into tumors. endpts.com/pd-l1-pioneer-lie…

PD-L1 pioneer Lieping Chen, Rachel Humphrey spin out new biotech to break down the door on cold...

In 2015, Lieping Chen — the I/O researcher whose early work established the PD-1/PD-L1 as a cancer target and the co-founder of Amplimmune, bought out by AstraZeneca in a $500 million ...

endpoints.news
4
4
Load more